Latest News
Alligator Bioscience enters strategic partnership with Aptevo Therapeutics
21 July 2017 - Swedish immuno-oncology antibody developer Alligator Bioscience (STO: ATORX) has entered into a strategic partnership with Seattle-based biotech Aptevo Therapeutics (NASDAQ: APVO), the company confirmed on Friday.The strategic alliance...
Takeda and Schrödinger form multi-year, multi-target research collaboration
21 July 2017 - Takeda Pharmaceutical Company Ltd (TYO: 4502) and privately-held company Schrödinger Inc have formed a multi-target research collaboration that will align with Takeda's core therapeutic areas of interest, the Japanese company...
Cantargia's clinical trial application for CAN04 is approved
21 July 2017 - Swedish biotech Cantargia AB's clinical trial application to study the antibody CAN04 in patients with cancer has been granted approval by the regulatory authorities as well as the ethics committees in Denmark and Norway, the comp...
LIDDS signs research agreement with major European pharma
21 July 2017 - LIDDS AB has signed a research agreement with a major pharmaceutical company, giving it an exclusive option right to leverage LIDDS' NanoZolid technology for the development of an injectable, controlled-release formulation for can...
European Commission approves Vifor Pharma's hyperkalaemia treatment Veltassa
21 July 2017 - The European Commission has approved Swiss pharmaceutical firm Vifor Pharma's (SWX: GALE) treatment for elevated serum potassium levels (hyperkalaemia), the company reported on Friday.The drug in question, patiromer, is to be mark...